Home - Products - Others - Other Targets - Ecdysis-Triggering Hormone (Manduca sexta)

Ecdysis-Triggering Hormone (Manduca sexta)

CAS No. 172519-53-8

Ecdysis-Triggering Hormone (Manduca sexta) ( ——— )

Catalog No. M41361 CAS No. 172519-53-8

Ecdysis-Triggering Hormone (Manduca sexta) ; Mas-ETH

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ecdysis-Triggering Hormone (Manduca sexta)
  • Note
    Research use only, not for human use.
  • Brief Description
    Ecdysis-Triggering Hormone (Manduca sexta) ; Mas-ETH
  • Description
    Ecdysis-Triggering Hormone (Manduca sexta) ; Mas-ETH
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    172519-53-8
  • Formula Weight
    2941.45
  • Molecular Formula
    C127H206N36O38S3
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (S,R,S)-AHPC-PEG2-NH...

    (S,R,S)-AHPC-PEG2-NH2 dihydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker.

  • A-196

    A-196 is a potent and selective inhibitor of SUV420 h1 and SUV420 h2 with IC50 values of 0.025 and 0.144 μM, respectively.

  • Laurotetanine

    Laurotetanine ((+)-Laurotetanine) is an potent and orally active isoquinoline alkaloid and could be extracted from the roots of Litsea cubeba (Lour.) Pers. Laurotetanine exerts an anti-asthmatic effect by inhibition of IgE, histamine, and inflammatory reactions via down-regulating MUC5AC and NF-κB signaling pathways.